| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.44B | +31.9% |
| Cost of Revenue | $7.61B | +25.1% |
| R&D Expense | $14.0M | +40.0% |
| SG&A Expense | $774.0M | +46.6% |
| Operating Income | $906.0M | +122.6% |
| Interest Expense | $197.0M | +60.2% |
| Pre-tax Income | $716.0M | +147.8% |
| Income Tax | $194.0M | +162.2% |
| Net Income | $522.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.0M | -12.8% |
| Accounts Receivable | $804.0M | +2.4% |
| Inventory | $1.61B | +15.8% |
| Current Assets | $2.71B | +8.2% |
| Total Assets | $10.33B | -1.2% |
| Current Liabilities | $1.93B | -5.7% |
| Long-term Debt | $5.10B | -10.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.09B | +79.0% |
| Investing Cash Flow | -$435.0M | +81.8% |
| Financing Cash Flow | -$666.0M | -137.5% |
| +155.9% |
| EPS (Basic) | $1.69 | +144.9% |
| EPS (Diluted) | $1.69 | +148.5% |
| Stockholders' Equity |
| $2.15B |
| +13.6% |